A Study to Investigate Safety of GS-248 and Efficacy on Raynauds' Phenomenon in Systemic Sclerosis
Clinical trial NCT04744207 · COMPLETED
Trial details
- NCT number
- NCT04744207
- Sponsor
- Gesynta Pharma AB
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-29
- Primary completion
- 2022-06-15
- Enrollment
- 94
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.